1
10–20 years before symptoms
For Clinicians
See what routine MRI cannot show alone.
White Scan turns a structural brain MRI into Alzheimer's pathology insight—with an automated amyloid report.
Book a DemoThe Clinical Gap
Pathology precedes symptoms.
Actionable PhaseSilent pathology + Early phase
2
Pre-symptomatic
Early phase
3
Symptomatic
Symptoms emerge
4
Clinical pathway
Diagnosis & care
Where White Scan adds clinical value
White Scan · Before symptomsEarlier assessment
White Scan · After symptoms emergeDifferential diagnosis & clinical phenotyping
White Scan · LongitudinalPotential monitoring of disease progression & treatment outcomes
White Scan uses are subject to ongoing clinical validation and applicable regulatory requirements.
White Scan supports assessment before and after symptom presentation. It does not provide a standalone diagnosis.
Beyond Routine MRI
One Scan. Multiple Insights.
3D T1-Weighted MRI
Shows brain anatomy and structural change for radiologist interpretation.
White Scan®
Adds MRI-derived surrogate amyloid burden and an automatically generated report.
Two Clinical Uses
Insight where clinical questions begin.
Screening support
For appropriate asymptomatic or at-risk adults as part of clinician-led assessment.
Clinical decision aid
Supports differential diagnosis, clinical phenotyping and treatment planning within the full clinical context.
The Analysis Report
Designed to be read at a glance.
Amyloid status
An explicit amyloid-positive or amyloid-negative result.
Global amyloid burden
A composite score with threshold-based classification.
Regional insight
Indications of regional amyloid deposition across the brain.
The fully automated White Scan report must be interpreted alongside clinical assessment, history, the radiologist's MRI report, volumetry and other relevant information.
Imaging Input
Complete whole-brain
3D T1-weighted MRI.
CoverageWhole brain
Acquisition3D T1-weighted
CompatibilityAny scanner. Any field strength. Anywhere.
Evaluated against gold-standard biomarkers
Evaluated against established biomarker references.
Amyloid PETAV45 florbetapir
Cerebrospinal fluidtTau/Aβ42
Validation studies are in progress at the Brain Health Clinic at South London and Maudsley NHS Foundation Trust to support wider clinical adoption.
Research and clinical partners
See White Scan in practice
Book a 30-minute clinical walkthrough.
Online demos can be booked directly. In-person demos are subject to availability and location—please contact us.
Book a DemoAlready Have an MRI?
Remote processing is available.
For a complete whole-brain 3D T1-weighted MRI in DICOM format, contact us for secure transfer instructions.
Email Silver Matter